tetracycline hydrochloride · TETRACYCLINE HYDROCHLORIDE 250 mg/1 · Capsule · Oral · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
NDC 23155-0017-01 · 100 CAPSULE in 1 BOTTLE · NDA · View full market →
9 companies supply this market — a reasonable cushion if one runs into trouble. The price is up 12% over the past year, to $0.8029 per unit.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Matched to CMS's representative package for this drug (NDC 69238-1522-01) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Actavis Pharma, Inc. | TETRACYCLINE HYDROCHLORIDE 250 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Amneal Pharmaceuticals NY LLC | TETRACYCLINE HYDROCHLORIDE 500 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Amneal Pharmaceuticals NY LLC | TETRACYCLINE HYDROCHLORIDE 250 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Bryant Ranch Prepack | TETRACYCLINE HYDROCHLORIDE 500 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | TETRACYCLINE HYDROCHLORIDE 500 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Breckenridge Pharmaceutical, Inc. | TETRACYCLINE HYDROCHLORIDE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Breckenridge Pharmaceutical, Inc. | TETRACYCLINE HYDROCHLORIDE 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC. | TETRACYCLINE HYDROCHLORIDE 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC. | TETRACYCLINE HYDROCHLORIDE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals Inc. | TETRACYCLINE HYDROCHLORIDE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals Inc. . | TETRACYCLINE HYDROCHLORIDE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | TETRACYCLINE HYDROCHLORIDE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | TETRACYCLINE HYDROCHLORIDE 250 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | TETRACYCLINE HYDROCHLORIDE 250 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Actavis Pharma, Inc. | TETRACYCLINE HYDROCHLORIDE 500 mg/1 | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "tetracycline hydrochloride — NDC 23155-0017-01," retrieved September 3, 2026, https://drugdashboards.com/drug/23155001701.
Free to cite with attribution — see how the data is put together.